EU To Offer Solution To Post-Brexit Regulatory Problems In Northern Ireland
One-Year ‘Grace Period’ Is Nearing Its End
The EU is preparing a formal proposal for ensuring the continued long-term supply of medicines from Great Britain to Northern Ireland from next year, but it will require "enhanced enforcement" by the UK authorities.
You may also be interested in...
As political tensions between the UK and EU mount over the Northern Ireland Protocol instigated as part of the pair’s Brexit agreement, the off-patent industry is growing increasingly concerned that regulatory uncertainty will put supply at risk.
New recommendations could result in more effective prescribing and fewer adverse events.
Coronavirus Notebook: UK Rolls Out Ronapreve To Hospitalized Patients, Drug Safety Unit Reviews mRNA Vaccine Heart Inflammation Link
Pressure is growing on richer countries to share their excess vaccine doses, and the European Parliament has passed legislation intended to strengthen the EU’s health security framework and make joint vaccine procurement more transparent.